Conventional phase 3 trials do not provide key information about the overall effect of introducing a new tuberculosis vaccine programme and so are missing crucial information for policy makers, argue experts in a personal view in Lancet Microbe.
Conventional phase 3 trials do not provide key information about the overall effect of introducing a new tuberculosis vaccine programme...